Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease

Abroad (travel likely)Recruiting

Conditions

MASLD · Fatty Liver

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henry Ford Health System, Detroit, Michigan, United States
Contact: Study coordinator (Menghua Tao, Ph.D.) · mtao1@hfhs.org · 3138768471

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluating the Pharmacokinetics and Safety of Miricorilant

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis · Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Abroad (travel likely)RecruitingPHASE1

San Antonio, United States

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · Fatty Liver Disease, Nonalcoholic · Overweight (BMI > 25)

Abroad (travel likely)RecruitingPHASE2

Girona, Spain

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

MASLD · MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) · NAFLD

Abroad (travel likely)Recruiting

La Jolla, United States

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · NAFLD - Non-Alcoholic Fatty Liver Disease

Abroad (travel likely)Recruiting

Seattle, United States